Cancer Therapeutics Market Could Reach $89 Billion by 2011, Says a New Report Available From Piribo.com.LONDON -- Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report on the cancer therapeutics market. "Cancer Therapeutics: The Worldwide Market" forecasts that the cancer therapeutics market will grow from around $46 billion in 2006 to more than $89 billion by 2011. The potential for improved disease outcomes is vast and targeted cancer therapeutics are a very exciting prospect, offering the opportunity to improve patient survival from serious illnesses. With the market expecting more than $11 billion new therapeutics to gain approval within the next four years a global market of $89 billion may be a modest projection. Innovation has been and remains the key to growth with the largest number of therapy approvals recorded in the US in 2006 and a further 50 therapies in Phase III Noun 1. phase III - a large clinical trial of a treatment or drug that in phase I and phase II has been shown to be efficacious with tolerable side effects; after successful conclusion of these clinical trials it will receive formal approval from the FDA or awaiting approval. This study examines the global market for therapies for a broad range of cancers including: bladder, breast, cervical, colorectal, kidney, leukemia leukemia (l  kē`mēə), cancerous disorder of the blood-forming tissues (bone marrow, lymphatics, liver, spleen) characterized by excessive production of immature or mature , liver, lung, lymphoma, melanoma, multiple myeloma multiple myelomaA malignant proliferation of abnormal plasma cells that populate the marrow-containing bones of the body. The affected plasma cells produce myeloma protein, a monoclonal antibody that replaces normal antibodies in the blood, thereby increasing susceptibility , ovarian ovarian /ovar·i·an/ (o-var´e-an) pertaining to an ovary or ovaries. ovarian pertaining to an ovary. ovarian agenesis , and prostate among others. Therapy types covered in the report include chemotherapy, hormone and radiation therapy, immunotherapy and biotherapy biotherapy /bio·ther·a·py/ (-ther´ah-pe) biological therapy. bi·o·ther·a·py n. Treatment of disease with biologicals, such as vaccines. , and adjunctive therapies adjunctive therapy Medtalk A therapeutic maneuver(s) with an ancillary role in treating a disease by ↓ M&M, but not part of the immediate therapy required to stabilize the Pt. Cf Adjuvant therapy. . It also includes extensive coverage of research and development pipelines, in-depth company profiles, four-region geographic breakdowns, over 160 tables and figures and more. "Cancer Therapeutics: The Worldwide Market" is available in pdf format from Piribo. For more information, go to: http://www.piribo.com/search/results.html?k=KAL111&x=0&y=0 Piribo product ID: KAL111 About Piribo. Piribo (http:www.piribo.com) is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 6,000 English language English language, member of the West Germanic group of the Germanic subfamily of the Indo-European family of languages (see Germanic languages). Spoken by about 470 million people throughout the world, English is the official language of about 45 nations. titles including, market reports, studies and books and is the UK's largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. The company was established in 2004. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion